From: NephroCheck data compared to serum creatinine in various clinical settings
ID | Age | Sex | BSL sCr | BSL GFR | AKI Stage | Reason AKI | Peak AKIRisk | Outcome/sCr | Disease | Surgeries |
---|---|---|---|---|---|---|---|---|---|---|
1 | 66 | m | 11.29 | 4.5 | End Stage | IRI | 1.6 | transplantectomy dialysis (0,5 m) | CKD, HTN | cadaver KTX |
2 | 38 | m | 7.26 | 16.11 | End Stage | IRI | 1.86 | 3,48 (14 m) | CKD, HTN, mitral and aortic valve regurgitation | cadaver KTX |
3 | 66 | m | 1.4 | 56.55 | stage 3 | prerenal, hypotension, shock | 4.74 | 1,53 (19 m) | CKD, KTX, AKI, cardiomyopathy, afib | thoracotomy |
4 | 69 | f | 1.21 | 44.12 | stage 3 | prerenal | 8.11 | 1,37 (19 m) | CKD, aortic stenosis, CHD, HTN, NIDDM | Valve replacement, CPR, acute CABG |
5 | 77 | m | 1.66 | 43.14 | stage 3 | prerenal, shock | 5.86 | Death | CTEPH, hyponatremia | none |
6 | 70 | f | 1.77 | 31.58 | stage 3 | contrast media | 0.38 | 1,58 (12 m) | CKD, CHD, HTN, afib, IDDM, diabetic nephropathy | none |
7 | 73 | m | 1.3 | 64.63 | No AKI | contrast media | 3.12 | 1,26 (3 m) | HTN, mitral and aortic valve regurgitation, afib | none |
8 | 56 | f | unknown | unknown | stage 3 | acute hepatits B | 73 | Lost to follow up | AKI, acute hepatitis B | LTX |
9 | 78 | m | 8.2 | 6.79 | End Stage | tubular injury membranous GN | 18 | 5,48 (12 m) | CKD, HTX, HTN, NIDDM | none |
10 | 41 | m | 0.93 | 98.18 | No AKI | toxic insult | 4.08 | 1,16 (2 m) | signet ring cell carcinoma of gaster | none |
11 | 54 | m | 0.67 | 123.59 | No AKI | toxic insult | 2.61 | 0,52 (9 m) | Squamous cell carcinoma of the esophagus, HTN | none |
12 | 57 | m | 0.73 | 107.46 | No AKI | toxic insult | 2.7 | 1,04 (13 m) | hypopharyngeal carcinoma | none |